The cartilage repair market has seen considerable growth due to a variety of factors.
• In recent years, there has been a significant increase in the size of the cartilage repair market. It is projected to expand from $1.42 billion in 2024 to $1.63 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 14.4%.
Factors contributing to this growth in the previous period include a surge in joint disorder cases, increased awareness and diagnosis rates, a rise in healthcare spending, and partnership and collaboration initiatives.
The cartilage repair market is expected to maintain its strong growth trajectory in upcoming years.
• The dimensions of the cartilage repair market is set to witness accelerated expansion in the forthcoming years. The market size is predicted to reach $2.57 billion by 2029, expanding at a compound annual growth rate (CAGR) of 12.1%.
Factors such as an increasing aging population, a surge in sports-related injuries, robust regulatory backing for advanced therapeutic approaches, and a growing patient inclination towards non-invasive procedures contribute to the growth during this forecast period. Key trends that are expected to prevail during the forecast period are advancements in technology, regulatory endorsements, standardization, patient predilection for biologics, and advancements in healthcare infrastructure.
The escalation in road mishaps and sports-related physical injuries is anticipated to fuel the expansion of the cartilage repair market. Road mishaps frequently involve vehicles, pedestrians, or cyclists on streets or public highways. Sports-related injuries, on the other hand, are those sustained while engaged in diverse sports and physical exercises. A spike in both of these contributes significantly to the demand for cartilage repair procedures. These procedures aim to restore damaged cartilage, relieve pain, and enhance joint functions disrupted by road and sports-related injuries. For example, nearly 1.3 million individuals lose their lives annually to road traffic accidents, as reported by the World Health Organization - a US-based specialized health agency, in June 2022. Similarly, Howden Group Holdings, a UK-based insurance firm, reported in October 2024 that under-21 players took off an average of 43.92 days per injury in the 2023-24 premier league season, up from 26.5 days in the 2022-23 season. Thus, the spike in road mishaps and sports-related physical injuries is leading the expansion of the cartilage repair market. Cartilage Repair Market Driver: Increasing Diabetes And Obesity Rates Pushing The Growth of The Cartilage Repair Market
The cartilage repair market covered in this report is segmented –
1) By Treatment Modality: Cell-Based, Non-Cell-Based
2) By Site: Knee, Hip, Ankle And Foot, Other Application Sites
3) By Application: Hyaline Cartilage, Fibrocartilage
4) By End User: Hospital And Clinic, Ambulatory Surgical Center (ASC), Other End-Users
Subsegments:
1) By Cell-Based Treatments: Autologous Chondrocyte Implantation (ACI), Stem Cell Therapy, Matrix-Induced Autologous Chondrocyte Implantation (MACI)
2) By Non-Cell-Based Treatments: Scaffold-Based Treatment, Osteochondral Grafts, Synthetic Implants
Leading firms in the cartilage repair market are introducing sophisticated products, such as biologic cartilage repair solutions, to enhance treatment choices for cartilage damage and foster natural recovery. Biologic cartilage repair solutions are treatments originating from biological sources like cells, tissues, or growth factors that aim to fix or rejuvenate damaged cartilage. For example, in August 2024, a US-based biotechnology company, Vericel, introduced and gained approval from a US-based federal healthcare protection agency for a product called MACI Arthro (autologous cultured chondrocytes on porcine collagen membrane). This novel biologic cartilage repair solution targets the treatment of knee cartilage defects. It permits medical professionals to manage symptomatic full-thickness cartilage defects of the knee up to 4 square cm in size with least invasive techniques. MACI Arthro facilitates the investigation and preparation of the defect site through minimal incisions using specially designed tools, marking a significant improvement over the conventional approach.
Major companies operating in the cartilage repair market report are:
• Johnson and Johnson Services Inc.
• Medtronic PLC
• Stryker Corporation
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Smith And Nephew PLC
• Arthrex Inc.
• CONMED Corporation Inc.
• Meril Life Sciences Pvt. Ltd.
• Medacta International SA
• RTI Surgical Inc.
• Japan MDM Inc.
• Vericel Corporation
• Anika Therapeutics Inc.
• Mathys AG Bettlach
• JRI Orthopedics Ltd.
• Auxein Medical ltd.
• MEDIPOST Co Ltd.
• DePuy Synthes Companies
• Arthro Kinetics AG
• Waldemar Link GmbH and Co.KG
• Osiris Therapeutics Inc.
• Teijin Nakashima Medical Co Ltd.
• Collagen Solutions LLP
• BioTissue SA
• ISTO Technologies Inc.
• Regentis Biomaterials Ltd.
• Histogenics Corporation
• Evolutis India Pvt. Ltd.
North America was the largest region in the cartilage repair market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage repair market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.